Related Experiment Video
Updated: Aug 9, 2026
![Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F55537.jpg&w=3840&q=50)
Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases
Published on: May 29, 2017
Research Progress on 18F-Labeled Agents for Imaging of Myocardial Perfusion with Positron Emission Tomography
Tiantian Mou1, Xianzhong Zhang2
1Department of Nuclear Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China. mtt207@163.com.
Insights
Fluorine-18 labeled myocardial perfusion imaging (MPI) tracers show promise for diagnosing coronary artery disease (CAD). This review covers current research and future directions for these vital diagnostic tools.
Area of Science:
- Nuclear medicine
- Radiochemistry
- Cardiology
Background:
- Coronary artery disease (CAD) remains a leading global cause of mortality.
- Myocardial perfusion imaging (MPI) is crucial for non-invasive CAD diagnosis and prognosis.
- Current MPI agents have limitations in meeting clinical demands.
Purpose of the Study:
- To review the advancements in 18F-labeled MPI tracers.
- To summarize the basic research data of these tracers.
- To outline future research directions in MPI tracer development.
Main Methods:
- Literature review of 18F-labeled MPI tracers.
- Analysis of basic research data for selected tracers.
- Discussion of clinical applications and future potential.
Main Results:
- Significant progress has been made in developing 18F-labeled MPI tracers.
- Various 18F-labeled tracers exhibit promising characteristics for myocardial perfusion assessment.
- The review consolidates current knowledge on tracer performance and development.
Conclusions:
- 18F-labeled tracers represent a significant advancement in MPI for CAD.
- Further research is needed to optimize existing tracers and develop novel ones.
- These tracers hold great potential for improving the diagnosis and management of CAD.
Abstract:
Coronary artery disease (CAD) is the leading cause of death in the world. Myocardial perfusion imaging (MPI) plays a significant role in non-invasive diagnosis and prognosis of CAD. However, neither single-photon emission computed tomography nor positron emission tomography clinical MPI agents can absolutely satisfy the demands of clinical practice. In the past decades, tremendous developments happened in the field of 18F-labeled MPI tracers. This review summarizes the current state of 18F-labeled MPI tracers, basic research data of those tracers, and the future direction of MPI tracer research.
More Related Videos
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET

